XML 40 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Data
 12 Months Ended
Mar. 31, 2012
Segment Data  
Segment Data

13.  Segment Data

 

Our operations are organized into two reporting segments:  Biological Indicators and Instrumentation Products, as set forth in the following tables.

 

(Dollars in Thousands)

 

Biological
Indicators

 

Instrumentation
Products

 

Total

 

Year ended March 31, 2012

 

 

 

 

 

 

 

Revenue

 

$

20,423

 

$

19,193

 

$

39,616

 

Operating Income

 

5,875

 

6,602

 

12,477

 

Other (Income) and Expense

 

161

 

(15

)

146

 

Capital Expenditures

 

299

 

384

 

683

 

Depreciation

 

494

 

231

 

725

 

Amortization

 

1,331

 

159

 

1,490

 

 

 

 

 

 

 

 

 

Year ended March 31, 2011

 

 

 

 

 

 

 

Revenue

 

$

16,823

 

$

17,404

 

$

34,227

 

Operating Income

 

4,007

 

5,857

 

9,864

 

Other (Income) and Expense

 

125

 

(12

)

113

 

Capital Expenditures

 

2,461

 

184

 

2,645

 

Depreciation

 

459

 

202

 

661

 

Amortization

 

1,024

 

159

 

1,183

 

 

 

 

 

 

 

 

 

Total assets

 

 

 

 

 

 

 

March 31, 2012

 

$

33,385

 

$

17,311

 

$

50,696

 

March 31, 2011

 

32,779

 

17,781

 

50,560

 

 

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows:

 

 

 

Year Ended March 31,

 

(Dollars in Thousands)

 

2012

 

2011

 

Net revenues from unaffiliated customers:

 

 

 

 

 

United States

 

$

23,770

 

$

21,053

 

Foreign (no country exceeds 10% of total)

 

15,846

 

13,174

 

 

All long-lived assets are located in the United States.